UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 23, 2013
SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware |
001-34465 |
20-1764048 |
Delaware |
001-31441 |
23-2872718 |
(State or Other Jurisdiction of |
(Commission File Number) |
(I.R.S. Employer |
4714 Gettysburg Road, P.O. Box 2034
Mechanicsburg, PA 17055
(Address of Principal Executive Offices) (Zip Code)
(717) 972-1100
(Registrants telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12) |
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective January 1, 2014, the Boards of Directors (the Boards) of Select Medical Holdings Corporation, a Delaware corporation (Holdings), and Select Medical Corporation, a Delaware corporation (Select), appointed David S. Chernow to serve as President and Chief Executive Officer of Holdings and Select.
Mr. Chernow, 56, has served as President of Holdings and Select since September 2010. He has held various additional executive officer titles with Holdings and Select since September 2010. He previously served on Holdings and Selects Boards of Directors from August 2005 to September 2010. From May 2007 to February 2010, Mr. Chernow served as the President and Chief Executive Officer of Oncure Medical Corp. He will continue to report directly to Mr. Robert A. Ortenzio.
Robert A. Ortenzio, 56, has been appointed to serve as Holdings and Selects Executive Chairman and Co-Founder effective on January 1, 2014. Mr. Ortenzio has served as Holdings and Selects Chief Executive Officer since February 2005. He will continue to serve as a member of Holdings and Selects Boards of Directors. In his role as Executive Chairman and Co-Founder, Mr. Ortenzio will continue to focus on overall company strategy, mergers and acquisitions and government and investor relations. Mr. Ortenzio is the son of Mr. Rocco A. Ortenzio.
Rocco A. Ortenzio, 81, has been appointed to serve as Holdings and Selects Vice Chairman and Co-Founder effective on January 1, 2014. Mr. Ortenzio has served as Holdings and Selects Executive Chairman since February 2005. He will continue to serve as a member of Holdings and Selects Boards of Directors. Mr. Ortenzio is the father of Mr. Robert A. Ortenzio.
Item 7.01 Regulation FD Disclosure.
On December 23, 2013, Holdings issued a press release announcing the matters discussed above. A copy of the press release is attached as Exhibit 99.1 to this report.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Description |
|
|
|
99.1 |
|
Press Release, dated December 23, 2013. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned hereunto duly authorized.
|
SELECT MEDICAL HOLDINGS CORPORATION | |
|
SELECT MEDICAL CORPORATION | |
|
| |
Dated: December 23, 2013 |
By: |
/s/ Michael E. Tarvin |
|
Name: |
Michael E. Tarvin |
|
Title: |
Executive Vice President, General Counsel and Secretary |
Exhibit 99.1
FOR IMMEDIATE RELEASE |
4714 Gettysburg Road Mechanicsburg, PA 17055
NYSE Symbol: SEM | |
Select Medical Holdings Corporation Announces
Year-End Promotions for Certain Executive Officers
MECHANICSBURG, PENNSYLVANIA December 23, 2013 Select Medical Holdings Corporation (the Company) (NYSE: SEM) today announced that its Board of Directors has appointed David S. Chernow to serve as its President and Chief Executive Officer effective on January 1, 2014. Mr. Chernow has served as the Companys President since September 2010. He previously served on the Companys Board of Directors from August 2005 to September 2010. Mr. Chernow will continue to report directly to Mr. Robert A. Ortenzio.
The Companys Board of Directors has appointed Robert A. Ortenzio to serve as the Companys Executive Chairman and Co-Founder effective on January 1, 2014. Mr. Ortenzio has served as the Companys Chief Executive Officer since February 2005. He will continue to serve as a member of the Companys Board of Directors. In his role as Executive Chairman and Co-Founder, Mr. Ortenzio will continue to focus on overall Company strategy, mergers and acquisitions and government and investor relations.
The Companys Board of Directors has appointed Rocco A. Ortenzio to serve as the Companys Vice Chairman and Co-Founder effective on January 1, 2014. Mr. Ortenzio has served as the Companys Executive Chairman since February 2005. He will continue to serve as a member of the Companys Board of Directors.
The Boards appointment of David as Chief Executive Officer recognizes his value to the Company and my confidence in the executive team we have in place to run the operations of a large company, said Mr. Robert A. Ortenzio.
Mr. Chernow stated, As President, I have been working extensively with the Companys senior leaders to understand the Companys many opportunities and challenges. I have confidence in the Companys strong leadership team, and look forward to continuing our efforts and working with our employees and partners to further strengthen our services and our position in the nations post acute care continuum.
Select Medical is a leading operator of specialty hospitals and outpatient rehabilitation clinics in the United States. As of September 30, 2013, Select Medical operated 108 long term acute care hospitals and 15 acute medical rehabilitation hospitals in 28 states and 997 outpatient rehabilitation clinics in 32 states and the District of Columbia. Select Medical also provides medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites. Information about Select Medical is available at www.selectmedical.com.
Certain statements contained herein that are not descriptions of historical facts are forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements due to factors including the following:
· changes in government reimbursement for our services due to the implementation of healthcare reform legislation, deficit reduction measures, and/or new payment policies may result in a reduction in net operating revenues, an increase in costs and a reduction in profitability;
· the failure of our specialty hospitals to maintain their Medicare certifications may cause our net operating revenues and profitability to decline;
· the failure of our facilities operated as hospitals within hospitals to qualify as hospitals separate from their host hospitals may cause our net operating revenues and profitability to decline;
· a government investigation or assertion that we have violated applicable regulations may result in sanctions or reputational harm and increased costs;
· acquisitions or joint ventures may prove difficult or unsuccessful, use significant resources or expose us to unforeseen liabilities;
· private third-party payors for our services may undertake future cost containment initiatives that limit our future net operating revenues and profitability;
· the failure to maintain established relationships with the physicians in the areas we serve could reduce our net operating revenues and profitability;
· shortages in qualified nurses or therapists could increase our operating costs significantly;
· competition may limit our ability to grow and result in a decrease in our net operating revenues and profitability;
· the loss of key members of our management team could significantly disrupt our operations;
· the effect of claims asserted against us could subject us to substantial uninsured liabilities; and
· other factors discussed from time to time in our filings with the Securities and Exchange Commission (the SEC), including factors discussed under the heading Risk Factors for the year ended December 31, 2012 contained in our annual report on Form 10-K filed with the SEC on February 26, 2013 and our quarterly report on Form 10-Q for the three months ended March 31, 2013, filed with the SEC on May 2, 2013.
Contact:
Investor inquiries:
Joel T. Veit
Senior Vice President & Treasurer
717/972-1100
ir@selectmedicalcorp.com
SOURCE: Select Medical Holdings Corporation
5C[G\>GYU@_"C_D+7_\`U[K_`.A5HE[K9S3G>K&/8Z?1--\0
M^&XC8JMOJ5D"3$?-,4D>>W((Q5Z/1[F_UF#5=5\I3:@BVMHB6"$]69B!D_08
M%9-E<'1_&-UU73[Z?[,HR<1S!%8?3=N/XTOB&X?4/$>F6V